News – 415 Capital

Newsroom

All years

2026

2025

2024

2023

2022

2021

2020

08.04.2026

Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors

07.04.2026

TRiCares Receives FDA Approval for TRICURE US IDE Pivotal Trial with the Topaz Tricuspid Valve Replacement System

07.04.2026

E2 (Endovascular Engineering) Raises $80 Million Series C to Advance Next-Generation Thrombectomy Platform as Pulmonary Embolism Treatment Evolves

20.01.2026

TRiCares Enters into €20 million Loan Agreement with the European Investment Bank

06.11.2025

TRiCares completes first TC-L 55mm Topaz implant in ongoing TRICURE EU Pivotal study

03.11.2025

E2 (Endovascular Engineering, Inc) Presents ENGULF Pivotal Study as a Late-Breaking Clinical Trial at the VIVA Conference

01.10.2025

Distalmotion Secures Third FDA Clearance for DEXTER® with Hysterectomy Indication

07.07.2025

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

07.07.2025

Aktiia gets FDA clearance for OTC cuffless blood pressure monitor

23.06.2025

E2 (Endovascular Engineering, Inc.) Announces Completion of Enrollment in the ENGULF Pivotal Cohort for Treatment of Pulmonary Embolism

28.05.2025

Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System

06.05.2025

CorFlow Therapeutics Appoints Chris O'Connell as Chairman of the Board of Directors

01.05.2025

Aktiia secures $42 million in Series B funding round and rebrands to Hilo

22.04.2025

R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE Drug Eluting Bioresorbable Scaffold

26.03.2025

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

25.03.2025

Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System

18.02.2025

415 Capital leads $42 Million Series B Financing in Endovascular Engineering to Advance the Treatment of Pulmonary Embolism

21.11.2024

Supira Medical Initiates U.S. Early Feasibility Study (EFS) for High-Risk PCI

04.11.2024

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

29.10.2024

415 Capital Announces €150 Million Second Fund and Key Appointments to Investment Committee to Support Breakthrough and Life-Saving Medical Innovation

28.10.2024

FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot

24.09.2024

TRiCares Announces First Topaz Implantation in EU Pivotal Study

10.09.2024

CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients

01.08.2024

Swiss Health Tech Startup, Aktiia, Names Industry Veteran, Rags Gupta, New CEO, As Part of Global Push to Transform Blood Pressure Monitoring and Management

25.07.2024

TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones

09.07.2024

R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs

12.06.2024

Aktiia receives CE Mark for CALFREE optical blood pressure technology

09.05.2024

R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO

25.03.2024

TRiCares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer

27.02.2024

Aktiia Secures CHF 27 Million (USD 30M) in Funding from Khosla Ventures and Others, Welcomes Daniel Graf as New President and Board Member to Accelerate Innovation in Hypertension Management

Press Release / 10.01.2024

Robotic Surgery pioneer Distalmotion partners with Proximie to extend surgical excellence globally

Press Release / 22.11.2023

Supira Medical receives FDA Breakthrough Device Designation as the company closed $40m in Series D Financing

Press Release / 19.04.2023

Distalmotion raises $150M to accelerate FDA Approval and Clinical Experience

Press Release / 15.09.2022

TRiCares Raises €47M In A First Closing Of Its Series C Financing To Fund Further Development Of Minimally Invasive Treatment For Tricuspid Regurgitation

Press Release / 28.02.2022

Supira Medical, A Shifamed Portfolio Company, Closes $30M In An Oversubscribed Series C Financing

Press Release / 26.01.2022

Distalmotion Raises $90M To Accelerate Adoption Of Surgical Robot Dexter

Press Release / 02.11.2021

Aktiia Closes $17.5M Series A Financing Round

Press Release / 23.06.2021

Israeli Medical Device Startup, Cardiac Success Ltd., Closes US $5.2M Series A Financing

Press Release / 20.06.2021

MedTech VC Firm 415 Capital Announces Strategic Alliance With European Healthcare Service Provider Uniphar Group PLC

Press Release / 08.10.2020

R3 Vascular Inc. Completes Series A Financing

Press Release / 05.05.2020

Supira Medical, a Shifamed Portfolio Company, Closes $35M in Series B Financing

Press Release / 14.01.2020